Function of N-terminal transactivation domain of the estrogen receptor requires a potential α-helical structure and is negatively regulated by the A domain

Molecular Endocrinology

Volumn 14, Issue 11, 2000, Pages 1849-1871

  Metivier, R ^a   Petit, F G ^a   Valotaire, Y ^a   Pakdel, F ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SACCHAROMYCES CEREVISIAE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TRANSACTIVATION; YEAST;

EID: 0033646066     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.11.0546     Document Type: Article

References (83)

1. Estrogens and breast cancer
2. Structure and function of estrogen receptors
3. A unified nomenclature system for the nuclear receptor superfamily
4. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor-β
5. Gene regulation by steroid hormones
6. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain
7. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
8. Estrogen receptor null mice: What have we learned and were will they lead us?
9. The steroid and thyroid hormone receptor superfamily
10. Ligand binding was acquired during evolution of nuclear receptors
11. Functional domains of the human estrogen receptor
12. The N-terminal DNA-binding 'zinc finger' of the estrogen and glucocorticoid receptors determines target gene specificity
13. Three amino-acids of the estrogen receptor are essential to its ability to distinguish an estrogen from a glucocorticoid response element
14. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor
15. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function
16. The human estrogen receptor has two independent nonacidic transcriptional activation functions
17. Identification of a third autonomous activation domain within the human estrogen receptor
18. Role of the two activating domains of the ustrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen
19. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells
20. Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast
21. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
22. Different positioning of the ligand-binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists
23. Estrogen receptor domains E and F: Role in dimerization and interaction with coactivator RIP-140
24. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor
25. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast
26. Estrogen receptor residues required for stereospecific ligand recognition and activation
27. Three-dimensional model for the hormone binding domains of steroid receptors
28. Steroid receptor induction of gene transcription: A two-step model
29. EMBO Workshop report Steroid and nuclear receptors
30. Nuclear receptor coregulators: Cellular and molecular biology
31. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation
32. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors
33. Estrogen receptor activation function 1 works by binding p160 coactivator proteins
34. p300 mediates functional synergism between AF-1, AF-2 of estrogen receptor α and β by interacting with the N-terminal A/B domains
35. Function of nuclear Co-repressor protein on thyroid hormone response elements is regulated by the receptor A/B domain
36. Promoter specificity of the two transcriptional activation functions of the human oestrogen receptor in yeast
37. Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor α-β heterodimeric complex
38. Synergism between a half-site and an imperfect estrogen-responsive element, and cooperation with COUP-TFI are required for estrogen receptor (ER) to achieve a maximal estrogen-stimulation of rainbow trout ER gene
39. Differential functional activities of rainbow trout and human estrogen receptors expressed in the yeast Saccharomyces cerevisiae
40. Two estrogen receptor (ER) isoforms with different estrogen-dependencies are generated from the trout ER gene
41. Two functionally different protein isoforms are produced from the chicken estrogen receptor-α gene
42. Hormone binding and transcription activation by estrogen receptors: Analyses using mammalian and yeast systems
43. Molecular basis of agonism and antagonism in the oestrogen receptor
44. Use of the yeast one-hybrid system to screen for mutations in the ligand-binding domain of the estrogen receptor
45. Purification, functional characterization, and crystallization of the ligand-binding domain of the retinoid X receptor
46. Crystal structure of the RAR γ ligand-binding domain bound to all-trans retinoic acid
47. A structural role for hormone in the thyroid hormone receptor
48. A canonical structure for the ligand-binding domain of nuclear receptors
49. Detection of secondary structure elements in proteins by hydrophobic cluster analysis
50. Deciphering protein sequence information through hydrophobic cluster analysis (HCA): Current status and perspectives
51. Distinct classes of transcriptional activating domains function by different mechanisms
52. Transcription in yeast activated by a putative ampbipatic α-helix linked to a DNA binding unit
53. A nonnatural transcriptional coactivator
54. Induced α-helix in the VP16 activation domain upon binding to a human TAF
55. Interdomain signaling in a two-domain fragment of the human glucocorticoid receptor
56. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
57. Mechanism of action of an acidic transcriptional activator in vitro
58. Critical structural elements of the VP16 transcriptional activation domain
59. Binding of general transcription factor TFIIB to an acidic activating region
60. Members of the steroid hormone receptor superfamily interact with TFIIB
61. Involvement of the transcription factor IID protein complex in gene activation by the N-terminal transactivation domain of the glucocorticoid receptor in vitro
62. Stimulation of RARα activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7
63. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human receptor A/B region
64. Phosphorylation of the human estrogen receptor
65. Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen site
66. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
67. Phosphorylation of serine-167 of the human oestrogen receptor is important for oestrogen response element binding and transcriptional activation
68. Potentiation of human estrogen receptor α transcriptional activation through phosphorylation of serines 104 and 106 by the cyclinA-CDK2 cbmplex
69. Estrogen receptors: Bioactivities and interactions with cell signaling pathways
70. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor α
71. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors
72. Ligand-dependent transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor
73. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators
74. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo
75. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen
76. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor
77. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins
78. Functional interactions between the estrogen receptor, DRIP205, a subunit of the heteromeric DRIP coactivator complex
79. A role for the Hsp40 Ydj1 in repression of basal steroid receptor activity in yeast
80. Steroid receptor interactions with heat shock protein and immunophilin chaperones
81. Reappraisal of the role of heat shock proteins as regulators of steroid receptor activity
82. Heme regulates transcription of the CYC1 gene of S. cerevisiae via an upstream activation site
83. Overexpression of rainbow trout estrogen receptor domains in Escherichia coli: Characterization and utilization in the production of antibodies for immunoblotting and immunochemistry